全文获取类型
收费全文 | 1139篇 |
免费 | 20篇 |
国内免费 | 5篇 |
专业分类
儿科学 | 2篇 |
妇产科学 | 10篇 |
基础医学 | 61篇 |
口腔科学 | 4篇 |
临床医学 | 29篇 |
内科学 | 25篇 |
皮肤病学 | 2篇 |
神经病学 | 344篇 |
特种医学 | 10篇 |
外科学 | 11篇 |
综合类 | 59篇 |
预防医学 | 24篇 |
眼科学 | 1篇 |
药学 | 528篇 |
中国医学 | 47篇 |
肿瘤学 | 7篇 |
出版年
2023年 | 6篇 |
2022年 | 23篇 |
2021年 | 16篇 |
2020年 | 15篇 |
2019年 | 19篇 |
2018年 | 24篇 |
2017年 | 20篇 |
2016年 | 31篇 |
2015年 | 23篇 |
2014年 | 65篇 |
2013年 | 81篇 |
2012年 | 45篇 |
2011年 | 55篇 |
2010年 | 51篇 |
2009年 | 61篇 |
2008年 | 85篇 |
2007年 | 53篇 |
2006年 | 40篇 |
2005年 | 50篇 |
2004年 | 59篇 |
2003年 | 40篇 |
2002年 | 32篇 |
2001年 | 25篇 |
2000年 | 13篇 |
1999年 | 18篇 |
1998年 | 13篇 |
1997年 | 13篇 |
1996年 | 9篇 |
1995年 | 6篇 |
1994年 | 6篇 |
1993年 | 14篇 |
1992年 | 13篇 |
1991年 | 11篇 |
1990年 | 8篇 |
1989年 | 4篇 |
1988年 | 10篇 |
1987年 | 6篇 |
1986年 | 11篇 |
1985年 | 10篇 |
1984年 | 14篇 |
1983年 | 8篇 |
1982年 | 9篇 |
1981年 | 9篇 |
1980年 | 6篇 |
1979年 | 5篇 |
1978年 | 3篇 |
1976年 | 5篇 |
1975年 | 7篇 |
1973年 | 4篇 |
1969年 | 2篇 |
排序方式: 共有1164条查询结果,搜索用时 15 毫秒
991.
目的比较不同抗抑郁剂在双相抑郁治疗过程中转相率的差异。方法对150例接受抗抑郁剂治疗的双相抑郁患者出现躁狂、轻躁狂、快速循环情况进行调查,并比较不同抗抑郁剂之间的差异。结果150例双相抑郁中,共有41例患者在治疗过程中转相,总发生率(转相率)34%。其中使用双重作用抗抑郁剂(DAA)患者的转相率为29.2%,使用选择性5-羟色胺回吸收抑制剂〈SSRI)的患者为12.7%,DAA与SSRI联合应用者为48.7%,三组间差异有统计学意义(Χ^2=11.87,P〈0.001)。DDA与SSRI联合应用者转相率高于SSRI,差异有统计学意义(Χ^2=16.06,P〈0.001,危险比OR=6.53);DAA转相率高于SSRI。差异有统计学意义(Χ^2=4.65,P〈0.01,OR=6.53);DAA与SSRI联合应用者转相率高于DAA(Χ^2=3.49,P〉0.05,OR=2.31)。转相与未转相者相比,心境稳定剂的应用差异有统计学意义(7/41,52/109,Χ^2=11.72,P〈0.001)。结论不同类型抗抑郁荆在双相抑郁治疗中引起的转相率有差异,其中联合使用抗抑郁剂的转相率最高,而心境稳定剂的联合应用有助于预防转相。 相似文献
992.
993.
Olfactory bulbectomised rats were treated with drugs and their rate of acquisition of a passive avoidance task was measured. The acquisition-rate, which is disturbed by the bilateral ablations, was completely restored by acute administration of fenfluramine or fluoxetine. Partial restoration was found with quipazine. Clonodine was without effect. Repeated treatments with impramine and mianserine improved passive avoidance of bulbectomised rats. Metergoline blocked these effects of imipramine and mianserin. These results indicate a serotonergic mechanism in the effect of antidepressants on olfactory bulbectomised rats. 相似文献
994.
Sharon C. Cheetham M. Rufus Crompton Cornelius L. E. Katona R. W. Horton 《Psychopharmacology》1990,102(4):544-548
5-HT1 and 5-HT1A binding sites were measured in brain tissue obtained at postmortem from 19 suicides, with definite evidence of depression, and 19 sex and age-matched controls. Thirteen of the depressed suicides had not been prescribed psychoactive drugs recently (drug-free suicides); six had been receiving antidepressant drugs, alone or in combination with other drugs (antidepressant-treated suicides). No significant differences were found in the number or affinity of 5-HT1 and 5-HT1A binding sites in frontal or temporal cortex between drug-free suicides and controls. The number of 5-HT1 sites was significantly lower (by 20%), affinity unaltered, in hippocampus and the affinity significantly lower (by 33%), number unaltered, in amygdala of drug-free suicides than controls. The number of 5-HT1 binding sites tended to be higher and the affinity lower in the antidepressant-treated compared to drug-free suicides, and significantly so in hippocampus. The present results, together with our previous studies, provide no evidence of altered cortical 5-HT markers in depressed suicides, but further emphasise abnormalities in the hippocampus. 相似文献
995.
J A García-Sevilla P J Hollingsworth C B Smnith 《European journal of pharmacology》1981,74(4):329-341
[3H]Clonidine and [3H]yohimbine have been used to characterize alpha 2-adrenoreceptors on human platelets. At 25 degrees C binding was rapid (t 1/2 of association, 1.8 and 2.7 min) and reversible (t 1/2 of dissociation, 0.5 and 8.2 min). The binding sites for [3H]clonidine and ]3H]yohimbine showed the specificity required for an alph 2-adrenoreceptor. The rank order of potency of inhibitors of [3h[clonidine binding was clonidine greater than yohimbine greater than phenylephrine greater than prazosin and of [3H]yohimbine binding was yohimbine greater than clonidine greater than phenylephrine greater than prazosin. Scatchard analysis of [3H]yohimbine binding indicated the existence of a single population of noninteracting sites (KD = 3.0 nM; Bmax = 188 fmol/mg protein). The high-affinity binding of [3H-clonidine had a lower affinity and a lower number of sites (KD = 5.0 nM; Bmax = 35 fmol/mg protein). [3H]Clonidine binding also showed evidence of a second site of much lower affinity and greater number (KD = 18.6 nM; Bmax = 77 fmol/mg protein) in 40% of the normal population. In vitro, antidepressant drugs competed with [3H]clonidine and [3H]yohimbine for the platelet alpha 2-adrenoreceptor. The rank order of potency of inhibitors of [3H]clonidine binding was mianserin greater than amitriptyline greater than iprindole greater than desipramine and of [3H]yohimbine binding was mianserin greater than amitriptyline greater than desipramine greater than iprindole. The inhibition constants (Ki) of adrenergic drugs and of various antidepressant drugs in competing with [3H]clonidine were correlated with the inhibition constants of these drugs in competing with [3H]yohimbine (r = 0.970; P less than 0.001) which suggests that both radioligands labelled the same alpha 2-adrenoreceptor on the human platelet. The inhibition of binding induced by all antidepressant drugs was competitive. In contrast, long-term administration of tricyclic antidepressant drugs to patients was recently found to be associated with a decrease in the number of binding sites for [3H]clonidine on platelet membranes. The present results indicate that both [3H]clonidine and [3H]yohimbine are useful tools for the quantification of alpha 2-adrenoreceptors on blood platelets and suggests that the specific binding of radiolabelled alpha 2-adrenoreceptor ligands to human platelet membranes might be used to monitor changes in alpha 2-adrenoreceptors during tricyclic antidepressant drug treatment. 相似文献
996.
J. Maj M. Papp G. Skuza K. Bigajska M. Zazula 《Journal of neural transmission (Vienna, Austria : 1996)》1989,76(1):29-38
Summary The paper examined the action of imipramine, (+)- and (–)-oxaprotiline, administered repeatedly to rats, on the behavioural effects of the dopamine D-1 and D-2 agonists, SKF 38393 and quinpirole, respectively. The three antidepressants studied, given in the single dose or repeatedly, attenuate the enhanced grooming evoked by SKF 38393. The locomotor hyperactivity, evoked by quinpirole administered s.c., is increased by repeated but not single-dose treatment with imipramine and (+)-oxaprotiline [but not with (–)-oxaprotiline]. Quinpirole at a low dose produces the locomotor hypoactivity which is attenuated by repeated, but not single-dose, treatment with the antidepressants studied here. Repeated imipramine and (+)-oxaprotiline [but not (–)-oxaprotiline] increase the locomotor activity effect of quinpirole injected into the nucleus accumbens.The results indicate that the enhanced responsiveness of the dopamine system, observed previously after repeated treatment with antidepressants, may be mediated by the dopamine D-2 receptors. 相似文献
997.
Controlled comparison of two doses of milnacipran (F 2207) and amitriptyline in major depressive inpatients 总被引:5,自引:0,他引:5
Marc Ansseau Remy von Frenckell Claudine Mertens Jules de Wilde Louis Botte Jean-Michel Devoitille Jean-Luc Evrard André De Nayer Philippe Darimont Guy Dejaiffe Jean Mirel Emile Meurice Marcel Parent Jean-Pierre Couzinier Jean-Paul Demarez Christiane Serre 《Psychopharmacology》1989,98(2):163-168
A multicenter study compared the antidepressant efficacy and the tolerance of two doses of milnacipran (50 mg and 100 mg/day) and amitriptyline (150 mg/day) in three parallel groups of 45 major depressive inpatients defined by Research Diagnostic Criteria. After a wash-out period of 4–7 days on placebo with lorazepam and/or nitrazepam if necessary, patients were randomly assigned to a daily dose of milnacipran 50 mg, milnacipran 100 mg or amitriptyline 150 mg reached on the 5th day and then stable over a 4-week period, with weekly assessments by means of the Montgomery and Asberg depression scale, the Hamilton depression scale, the Clinical Global Impressions (CGI) and the Target Emergent Signs and Symptoms. Results showed significant superiority of both milnacipran 100 mg/day and amitriptyline over milnacipran 50 mg/day at the end of the treatment period. However, amitriptyline induced a nonsignificant trend toward more rapid improvement after 2 weeks of treatment, mainly based on items related to insomnia, supporting more sedative properties of amitriptyline as compared to milnacipran. Anticholinergic side-effects were significantly lower with milnacipran than with amitriptyline, explaining why milnacipran 100 mg exhibited at the end of the treatment period, a nonsignificantly better efficacy index on the CGI. Moreover, in contrast to milnacipran, amitriptyline was responsible for a significant decrease in blood pressure and a significant weight gain. 相似文献
998.
The effects of acute administration of 10 different antidepressant drugs were examined on the performance of a two-way conditioned avoidance response in rats. The antidepressant drugs impaired avoidance behavior by decreasing avoidance responding and increasing the number of escape failures. The order of effectiveness for increasing overall response latency at a common dose of 10 mg/kg was: desipramine, maprotiline, protriptyline, (+) oxaprotiline, nortriptyline, imipramine, amitriptyline, (-) oxaprotiline, fluoxetine, and chlorimipramine. Avoidance behavior was impaired most by those antidepressant drugs that are also potent inhibitors of norepinephrine uptake. 相似文献
999.
The partial NMDA agonist D-cycloserine stimulates LH secretion in healthy volunteers 总被引:5,自引:5,他引:0
B. N. M. van Berckel C. Lipsch C. Gispen-de Wied H. J. Wynne M. A. Blankenstein J. M. van Ree R. S. Kahn 《Psychopharmacology》1998,138(2):190-197
Because of clinical interest in the effects of antidepressant drugs that exert their effects on multiple neurotransmitter
systems, the behavioral effects produced by combined treatment with an SSRI (fluoxetine) with a selective norepinephrine (NE;
desipramine) or dopamine (DA) reuptake inhibitor (buproprion) were examined in the forced swimming test (FST), a behavioral
test in rodents that predicts the clinical activity of antidepressants. Three additional compounds with mixed activity as
NE-5-HT reuptake inhibitors, milnacipran, duloxetine and venlafaxine, were also examined. Desipramine and fluoxetine both
reduced immobility in the FST, but desipramine increased only climbing behavior, whereas fluoxetine increased only swimming
behavior. The combination of fluoxetine with desipramine or bupropion increased both climbing and swimming behaviors at certain
doses, but higher doses of desipramine when combined with fluoxetine replaced swimming behavior with climbing behavior. The
mixed NE-5-HT reuptake inhibitors milnacipran and duloxetine reduced immobility and increased climbing behavior, but did not
alter swimming. Venlafaxine reduced immobility and increased swimming behavior, except at the highest dose tested (80mg/kg),
which increased both swimming and climbing behaviors. Thus, combining certain doses of pharmacologically selective monoamine
reuptake inhibitors, or the mixed reuptake inhibitor venlafaxine, produced a pattern of mixed active behaviors in the FST
(climbing and swimming) that may reflect the activity of multiple neurotransmitters, especially the combination of enhanced
5-HT and DA activity. The combination of higher doses of desipramine with fluoxetine, or compounds with mixed activity at
inhibiting NE and 5-HT reuptake, demonstrated effects similar to those of desipramine alone and may reflect inhibition of
the expression of serotonergic antidepressant behavioral effects by selective NE reuptake inhibitors.
Received: 10 June 1997/Final version: 19 August 1997 相似文献
1000.
The present document is the final of three parts of a review that focuses on recent data from clinical and animal research concerning the biochemical bases of depressive disorders, diagnosis, and treatment. Various treatments for depression, including psychotherapy, pharmacological, and somatic treatments, will be described in this third part. Also, some of the controversies in the field, as well as a summary of the most salient points of the review, will be discussed. Previous sections of this review dealt with the classification of depressive disorders and research techniques for studying the biochemical mechanisms of these disorders (Part I) and various transmitter/receptor theories of depressive disorder (Part II). 相似文献